Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy for malignant bone tumors.

N Jaffe1

  • 1University of Texas Medical School, Division of Pediatrics, M.D. Anderson Cancer Center, Houston.

The Orthopedic Clinics of North America
|July 1, 1989
PubMed
Summary

Chemotherapy significantly improves survival rates for bone cancers like osteosarcoma and Ewing's sarcoma. It aids in tumor removal, predicts treatment response, and helps control both primary tumors and micrometastases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review.

British journal of cancer·2014
Same author

Malignant bone tumors.

Pediatric annals·2014
Same author

De novo germline mutations of the p53 gene in young children with sarcomas.

Oncology reports·2011
Same author

Pediatric osteosarcoma - treatment of the primary tumor with intravenous cis-diamminedichloroplatinum-ii (cdp) - comparison of the results with the reported efficacy of intraarterial cdp.

International journal of oncology·2011
Same author

Is there a safe therapeutic window for delivery of chemotherapy prior to initiation of surgery and/or radiation-therapy for treatment of the primary tumor in children with rhabdomyosarcoma.

International journal of oncology·2011
Same author

Weight loading young chicks inhibits bone elongation and promotes growth plate ossification and vascularization.

Journal of applied physiology (Bethesda, Md. : 1985)·2005

Area of Science:

  • Oncology
  • Surgical Oncology
  • Medical Oncology

Background:

  • Malignant bone tumors, including osteosarcoma and Ewing's sarcoma, present significant treatment challenges.
  • Chemotherapy has emerged as a cornerstone in managing these aggressive cancers.

Purpose of the Study:

  • To evaluate the impact of chemotherapy on survival and treatment outcomes in malignant bone tumors.
  • To explore the role of chemotherapy in facilitating surgical resection and predicting treatment response.

Main Methods:

  • Review of clinical data and treatment outcomes for patients with osteosarcoma and Ewing's sarcoma.
  • Analysis of the effects of preoperative and adjuvant chemotherapy on tumor response and survival.

Main Results:

  • Chemotherapy achieved metastasis-free survival in 50-75% of osteosarcoma patients and 50-80% in Ewing's sarcoma patients.
  • Preoperative chemotherapy improved surgical resectability and allowed for prediction of treatment response.
  • Combination chemotherapy and radiation enhanced local tumor control.

Conclusions:

  • Chemotherapy is a critical component in the management of malignant bone tumors, significantly improving patient survival.
  • Chemotherapy's effects on primary tumors can guide adjuvant therapy decisions and potentially reduce the need for radiation, mitigating long-term side effects.

Related Experiment Videos